Welcome to our dedicated page for Rubicon Organics news (Ticker: ROMJF), a resource for investors and traders seeking the latest updates and insights on Rubicon Organics stock.
Rubicon Organics Inc. (ROMJF) generates frequent news as a Canadian licensed producer focused on organic certified, premium and super-premium cannabis products. Company announcements often emphasize its position as the Canadian leader in certified organic and premium cannabis, its vertically integrated operations, and the performance of its brands Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™.
News updates commonly include financial and operating results, where Rubicon Organics reports net revenue trends, Adjusted EBITDA, cash flow from operations, and market share in premium categories such as flower, pre-rolls, vapes, edibles, and topicals. These releases provide insight into how the company’s premium focus and cost discipline translate into operating performance over time.
Investors can also expect corporate and strategic announcements, such as the acquisition and licensing of the Cascadia facility in Hope, British Columbia, which the company states will expand production capacity by over 40%. Other news items cover credit agreements and financings, including capital loans and lines of credit secured against Cascadia, which Rubicon Organics plans to use for projects at its Pacifica and Cascadia facilities.
Additional coverage includes regulatory and licensing milestones, such as Health Canada licenses to cultivate, process, and store cannabis at Cascadia, as well as ESG reporting, executive appointments, and participation in investor conferences. Together, these updates give a detailed view of Rubicon Organics’ operations, capital structure, governance practices, and growth plans. For readers tracking ROMJF, the news feed offers a centralized way to follow developments in this premium-focused cannabis issuer.
Rubicon Organics (OTCQX: ROMJF) appointed Glen Ibbott as Chief Financial Officer and Corporate Secretary, effective after a six-month interim period, announced Nov 13, 2025. Mr. Ibbott has over 25 years of finance leadership in life sciences and cannabis, served as CFO of Aurora Cannabis from 2017–2024, and held senior roles including at QLT where he was involved in a $500 million merger.
The company said his prior six months as interim CFO demonstrated strategic impact while he holds a CPA and MBAs from Cornell and Queen’s. The appointment signals continuity in financial leadership as Rubicon scales premium cannabis operations and expands markets.
Rubicon Organics (OTCQX: ROMJF / TSXV: ROMJ) announced it secured $4,000,000 in additional credit agreements with Community Savings Credit Union on Nov 10, 2025. The debt package includes a $3.0M capital loan (5-year term, 10-year amortization, 6.79% annual interest) and a $1.0M line of credit (CSCU Basic Lending Rate + 5.50% monthly). The Credit Agreements are secured against the Cascadia Facility and are expected to be finalized within the next month. The company said proceeds will fund margin-accretive projects at its Pacifica and Cascadia facilities to support strategic growth while preserving balance sheet flexibility.
Rubicon Organics (OTCQX: ROMJF; TSXV: ROMJ) will release Q3 2025 financial results for the three and nine months ended September 30, 2025 after market close on Wednesday, November 12, 2025. The company will host a conference call to discuss results on Thursday, November 13, 2025 at 7:00 AM PT / 10:00 AM ET. Call details: Conference ID 89693, local dial-in +1 (289) 514 5100, toll-free North America +1 (800) 717 1738, and a webcast available via Rubicon Organics Q3 2025 Earnings Call registration.
Rubicon Organics (OTCQX: ROMJF) published its fifth annual ESG Report covering January 1 to December 31, 2024. The report highlights five-year progress since 2020 across business, governance, environment, and social metrics.
Key figures: net revenue rose 410% from $9.4M in 2020 to $49M in 2024; energy use increased 17% and water use increased 58% over the same period. Governance disclosures include board oversight and CEO pay ratio. Social metrics show 80% employee pride and 86% engagement survey participation (94% for temporary foreign workers).
Rubicon Organics (OTCQX: ROMJF) announced that its Cascadia facility in Hope, British Columbia, received a Health Canada licence to cultivate, process, and store cannabis.
The purpose-built, 47,500 sq ft indoor site adds 4,500 kg of annual production capacity, a 40% incremental increase that brings Rubicon's total premium annual capacity to 15,500 kg. Operations are underway and the company expects first revenue in H1 2026. Management said the facility uses advanced cultivation technologies and will support domestic demand and international market opportunities. Rubicon also renamed its Delta facility to Pacifica.
Rubicon Organics (OTCQX: ROMJF), Canada's leading premium licensed producer of organic certified cannabis products, has announced its participation in two upcoming investor events. The company will present at Small Cap Discoveries in Vancouver (September 29-30) and the Planet MicroCap Showcase in Toronto (October 21-23).
Additionally, Rubicon has engaged Atrium Research Corporation for research services at $3,500 monthly for 12 months starting October 1st, 2025, pending TSXV approval.
Rubicon Organics (OTCQX: ROMJF), Canada's leading premium organic cannabis producer, reported strong Q2 2025 financial results with net revenue of $15.0 million, up 24% year-over-year. The company achieved Adjusted EBITDA of $1.4 million and positive operating cash flow of $0.8 million.
Key developments include the acquisition of the Hope Facility, increasing production capacity by 40% to 15,500 kg annually, and completion of a $4.5 million private placement. The company expanded its product portfolio with the launch of 1964 Premium All-in-One Resin Vapes and maintained strong market share positions: 5.2% in premium flower/pre-rolls, 15.1% in resin vapes, and 26.2% in premium edibles.
For 2025, Rubicon expects growth in both revenue and Adjusted EBITDA, despite anticipated one-time costs of $1-2 million related to the Hope Facility start-up. The company is also exploring international market opportunities while maintaining focus on Canadian market leadership.
Rubicon Organics (OTCQX:ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has scheduled its Q2 2025 financial results release for August 18, 2025, before market open.
The company will host a conference call to discuss the results on the same day at 7:00 AM PT / 10:00 AM ET. Investors can access the call through local dial-in, toll-free North American number, or via webcast through the company's earnings call registration.
Rubicon Organics (OTCQX: ROMJF), a premium cannabis producer, held its Annual General and Special Meeting with 46.3% shareholder representation. Shareholders approved all proposed matters, including setting the board size at eight directors and electing all nominated directors with approval rates ranging from 85.7% to 95.8%.
The company announced a significant leadership change as Len Boggio steps down as Board Chair, transitioning to Chair of the Nomination and Governance Committee. Doris Bitz, an independent director since 2023 with over 30 years of CPG and manufacturing experience, has been appointed as the new Board Chair.
Shareholders also approved amendments to the company's Omnibus Equity Incentive Plan with 74.7% support. The plan allows for a maximum of 8,960,180 Common Shares for equity awards. Additionally, the company granted 1,024,576 DSUs to independent directors, vesting in twelve months.
Rubicon Organics (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis, has announced its upcoming Annual General and Special Meeting scheduled for July 31, 2025, at 10:00 AM PT. The meeting will be held at the Terminal City Club in Vancouver, with a live webcast option available.
The meeting agenda includes receiving 2024 financial statements, setting the board size at eight directors, electing directors, appointing PricewaterhouseCoopers LLP as auditors, and considering an amendment to the Omnibus Equity Incentive Plan to reserve 8,960,179 Common Shares for issuance. The record date for the meeting was set for June 25, 2025.